Table of Contents
ISRN Oncology
Volume 2012 (2012), Article ID 341408, 6 pages
http://dx.doi.org/10.5402/2012/341408
Review Article

Resectable Pediatric Nonrhabdomyosarcoma Soft Tissue Sarcoma: Which Patients Benefit from Adjuvant Radiation Therapy and How Much?

Department of Radiation Oncology, Stanford Cancer Center, 875 Blake Wilbur Drive, Stanford, CA 94305, USA

Received 17 December 2011; Accepted 9 January 2012

Academic Editors: H. Al-Ali, E. Boven, and E. A. Rakha

Copyright © 2012 Lynn Million and Sarah S. Donaldson. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. G. Ries, M. A. Smith, J. G. Gurney et al., Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995, Surveillance Research Program of the National Cancer Institute, 1999.
  2. R. B. Raney, J. R. Anderson, K. L. Brown et al., “Treatment results for patients with localized, completely resected (Group I) alveolar rhabdomyosarcoma on Intergroup Rhabdomyosarcoma Study Group (IRSG) protocols III and IV, 1984-1997: a report from the Children's Oncology Group,” Pediatric Blood and Cancer, vol. 55, no. 4, pp. 612–616, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. W. Crist, E. A. Gehan, A. H. Ragab et al., “The Third Intergroup Rhabdomyosarcoma Study,” Journal of Clinical Oncology, vol. 13, no. 3, pp. 610–630, 1995. View at Google Scholar · View at Scopus
  4. W. M. Crist, J. R. Anderson, J. L. Meza et al., “Intergroup rhabdomyosarcoma Study-IV: results for patients with nonmetastatic disease,” Journal of Clinical Oncology, vol. 19, no. 12, pp. 3091–3102, 2001. View at Google Scholar · View at Scopus
  5. H. M. Maurer, E. A. Gehan, M. Beltangady et al., “The Intergroup Rhabdomyosarcoma Study-II,” Cancer, vol. 71, no. 5, pp. 1904–1922, 1993. View at Google Scholar · View at Scopus
  6. A. Ferrari, R. Miceli, A. Rey et al., “Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: results of a pooled analysis from United States and European groups,” European Journal of Cancer, vol. 47, no. 5, pp. 724–731, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. S. L. Spunt, C. A. Poquette, Y. S. Hurt et al., “Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children's Research Hospital,” Journal of Clinical Oncology, vol. 17, no. 12, pp. 3697–3705, 1999. View at Google Scholar · View at Scopus
  8. C. B. Pratt, A. S. Pappo, P. Gieser et al., “Role of adjuvant chemotherapy in the treatment of surgically resected pediatric nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study,” Journal of Clinical Oncology, vol. 17, no. 4, pp. 1219–1226, 1999. View at Google Scholar · View at Scopus
  9. D. M. Parham, B. L. Webber, J. J. Jenkins III, A. B. Cantor, and H. M. Maurer, “Nonrhabdomyosarcomatous soft tissue sarcomas of childhood: formulation of a simplified system for grading,” Modern Pathology, vol. 8, no. 7, pp. 705–710, 1995. View at Google Scholar · View at Scopus
  10. H. M. Maurer, M. Beltangady, E. A. Gehan et al., “The Intergroup Rhabdomyosarcoma Study-I. A final report,” Cancer, vol. 61, no. 2, pp. 209–220, 1988. View at Google Scholar · View at Scopus
  11. M. L. Blakely, W. W. Spurbeck, A. S. Pappo et al., “The impact of margin of resection on outcome in pediatric nonrhabdomyosarcoma soft tissue sarcoma,” Journal of Pediatric Surgery, vol. 34, no. 5, pp. 672–675, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. K. B. Smith, D. J. Indelicato, J. A. Knapik et al., “Adjuvant radiotherapy for pediatric and young adult nonrhabdomyosarcoma soft-tissue sarcoma,” International Journal of Radiation Oncology Biology Physics, vol. 81, no. 1, pp. 150–157, 2011. View at Publisher · View at Google Scholar · View at PubMed
  13. S. L. Spunt, S. X. Skapek, and C. M. Coffin, “Pediatric nonrhabdomyosarcoma soft tissue sarcomas,” Oncologist, vol. 13, no. 6, pp. 668–678, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. L. Guillou, J. M. Coindre, F. Bonichon et al., “Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma,” Journal of Clinical Oncology, vol. 15, no. 1, pp. 350–362, 1997. View at Google Scholar · View at Scopus
  15. M. F. Okcu, M. Munsell, J. Treuner et al., “Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome,” Journal of Clinical Oncology, vol. 21, no. 8, pp. 1602–1611, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. T. M. Dantonello, C. Int-Veen, D. Harms et al., “Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults,” Journal of Clinical Oncology, vol. 27, no. 9, pp. 1446–1455, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. D. Orbach, H. McDowell, A. Rey, N. Bouvet, A. Kelsey, and M. C. Stevens, “Sparing strategy does not compromise prognosis in pediatric localized synovial sarcoma: experience of the International Society of pediatric oncology, malignant mesenchymal tumors (SIOP-MMT) Working Group,” Pediatric Blood and Cancer, vol. 57, no. 7, pp. 1130–1136, 2011. View at Publisher · View at Google Scholar · View at PubMed
  18. L. Guillou, J. Benhattar, F. Bonichon et al., “Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis,” Journal of Clinical Oncology, vol. 22, no. 20, pp. 4040–4050, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. M. Ladanyi, C. R. Antonescu, D. H. Leung et al., “Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients,” Cancer Research, vol. 62, no. 1, pp. 135–140, 2002. View at Google Scholar · View at Scopus
  20. M. Carli, A. Ferrari, A. Mattke et al., “Pediatric malignant peripheral nerve sheath tumor: the Italian and German Soft Tissue Sarcoma Cooperative Group,” Journal of Clinical Oncology, vol. 23, no. 33, pp. 8422–8430, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. A. A. Hayes-Jordan, S. L. Spunt, C. A. Poquette et al., “Nonrhabdomyosarcoma soft tissue sarcomas in children: is age at diagnosis an important variable?” Journal of Pediatric Surgery, vol. 35, no. 6, pp. 948–954, 2000, discussion 953–944. View at Google Scholar · View at Scopus
  22. R. A. Kleinerman, “Radiation-sensitive genetically susceptible pediatric sub-populations,” Pediatric Radiology, vol. 39, supplement 1, pp. S27–S31, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. G. H. Fletcher, “Elective irradiation of subclinical disease in cancers of the head and neck,” Cancer, vol. 29, no. 6, pp. 1450–1454, 1972. View at Google Scholar · View at Scopus
  24. D. Roberge, T. Skamene, A. Nahal, R. E. Turcotte, T. Powell, and C. Freeman, “Radiological and pathological response following pre-operative radiotherapy for soft-tissue sarcoma,” Radiotherapy and Oncology, vol. 97, no. 3, pp. 404–407, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. B. O'Sullivan, A. M. Davis, R. Turcotte et al., “Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial,” The Lancet, vol. 359, no. 9325, pp. 2235–2241, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. M. J. Krasin, A. M. Davidoff, X. Xiong et al., “Preliminary Results From a Prospective Study Using Limited Margin Radiotherapy in Pediatric and Young Adult Patients With High-Grade Nonrhabdomyosarcoma Soft-Tissue Sarcoma,” International Journal of Radiation Oncology Biology Physics, vol. 76, no. 3, pp. 874–878, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. C. Lin, S. S. Donaldson, J. L. Meza et al., “Effect of Radiotherapy Techniques (IMRT vs. 3D-CRT) on Outcome in Patients With Intermediate-Risk Rhabdomyosarcoma Enrolled in COG D9803-A Report From the Children's Oncology Group,” International Journal of Radiation Oncology, Biology, Physics. In press. View at Publisher · View at Google Scholar · View at PubMed
  28. B. Rombi, T. F. DeLaney, S. M. MacDonald et al., “Proton radiotherapy for pediatric Ewing's sarcoma: initial clinical outcomes,” International Journal of Radiation Oncology, Biology, Physics, vol. 1, no. 82(3), pp. 1142–1148, 2011. View at Publisher · View at Google Scholar · View at PubMed